Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Diabetes Research and Clinical Practice

• Publication date

  2007-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.DIABRES.2006.09.016PMID 17097186
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of diacylglycerol O‐acyltransferase 1 gene results in increased tumor necrosis factor‐α gene expression in 3T3‐L1 adipocytes

  2006cited by this paper
• Increased oxidative stress in obesity and its impact on metabolic syndrome.

  2004cited by this paper
• Monocyte chemoattractant protein 1 in obesity and insulin resistance

  2003cited by this paper
• Human Glycated Albumin Affects Glucose Metabolism in L6 Skeletal Muscle Cells by Impairing Insulin-induced Insulin Receptor Substrate (IRS) Signaling through a Protein Kinase Cα-mediated Mechanism*

  2003cited by this paper
• Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes.

  2002cited by this paper
• Advanced Glycation End Product-induced Apoptosis and Overexpression of Vascular Endothelial Growth Factor and Monocyte Chemoattractant Protein-1 in Human-cultured Mesangial Cells*

  2002cited by this paper
• Tumor necrosis factor-α is induced through phorbol ester- and glycated human albumin-dependent pathway in THP-1 cells

  2001cited by this paper
• Tumor necrosis factor-alpha is induced through phorbol ester--and glycated human albumin-dependent pathway in THP-1 cells.

  2001cited by this paper
• Leptin Induces Mitochondrial Superoxide Production and Monocyte Chemoattractant Protein-1 Expression in Aortic Endothelial Cells by Increasing Fatty Acid Oxidation via Protein Kinase A*

  2001cited by this paper
• Neurotoxicity of Advanced Glycation End‐Products for Cultured Cortical Neurons

  2000cited by this paper
• Immunological Evidence that Non-carboxymethyllysine Advanced Glycation End-products Are Produced from Short Chain Sugars and Dicarbonyl Compounds in vivo

  2000cited by this paper
• Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction.

  2000cited by this paper
• Endothelin Stimulates Glucose Uptake and GLUT4 Translocation via Activation of Endothelin ETA Receptor in 3T3-L1 Adipocytes*

  1999cited by this paper
• Detection of Noncarboxymethyllysine and Carboxymethyllysine Advanced Glycation End Products (AGE) in Serum of Diabetic Patients

  1999cited by this paper
• Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells

  1998cited by this paper
• Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease.

  1996cited by this paper
• Long-term assessment of glucose control by haemoglobin-AGE measurement.

  1996cited by this paper
• Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with oil red O

  1992cited by this paper
• Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

  1988cited by this paper

• Casein- and Soy-Based High-Protein Diets Differentially Affect Insulin Resistance and Adipose Tissue Advanced Glycation End Product Accumulation in Obese Diabetic Mice.

  2026cites this paper
• Is Type 2 Diabetes a Modifiable Risk Factor for the Evolution and Progression of Heart Failure With a Preserved Ejection Fraction?

  2025cites this paper
• Mechanism and implications of advanced glycation end products (AGE) and its receptor RAGE axis as crucial mediators linking inflammation and obesity

  2025cites this paper
• A Simple Experimental Approach to Understanding the Formation of Advanced Glycation End Products

  2025cites this paper
• The Advanced Glycation End-Products (AGE)–Receptor for AGE System (RAGE): An Inflammatory Pathway Linking Obesity and Cardiovascular Diseases

  2025cites this paper
• The RAGE Axis: A Relevant Inflammatory Hub in Human Diseases

  2024cites this paper
• Dietary advanced glycation end-products and their associations with body weight on a Mediterranean diet and low-fat vegan diet: a randomized, cross-over trial

  2024cites this paper
• Associations of Serum Insulin and Related Measures With Neuropathology and Cognition in Older Persons With and Without Diabetes

  2024cites this paper
• Dietary Restriction of Advanced Glycation End-Products (AGEs) in Patients with Diabetes: A Systematic Review of Randomized Controlled Trials

  2024cites this paper
• Effect of low vs high dietary-advanced glycation end products on insulin-sensitivity and inflammatory- markers among overweight/obese Asian-Indian adults-A randomised controlled trial

  2024cites this paper
• The contribution of adiponectin to diabetic retinopathy progression: Association with the AGEs-RAGE pathway

  2024cites this paper
• Receptor for the Advanced Glycation End Products (RAGE) Pathway in Adipose Tissue Metabolism

  2023cites this paper
• Transcriptome profile of skeletal muscle using different sources of dietary fatty acids in male pigs

  2023cites this paper
• Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy

  2023cites this paper
• RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer

  2023cites this paper
• Etiopathogenesis of insulin resistance

  2022cites this paper
• Association between diabetes and cancer. Current mechanistic insights into the association and future challenges

  2022cites this paper
• Association of α-Dicarbonyls and Advanced Glycation End Products with Insulin Resistance in Non-Diabetic Young Subjects: A Case-Control Study

  2022cites this paper
• Methylglyoxal induces multiple serine phosphorylation in insulin receptor substrate 1 via the TAK1-p38-mTORC1 signaling axis in adipocytes.

  2022cites this paper
• Calycosin ameliorates advanced glycation end product-induced neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease.

  2022cites this paper
• Glycation and a Spark of ALEs (Advanced Lipoxidation End Products) – Igniting RAGE/Diaphanous-1 and Cardiometabolic Disease

  2022cites this paper
• Effects of Diabetes Mellitus upon Sperm Quality Insight into Molecular Level

  2022cites this paper
• Effectiveness of Early Advanced Glycation End Product Accumulation Testing in the Diagnosis of Diabetes: A Health Risk Factor Analysis Using the Body Mass Index as a Moderator

  2022cites this paper
• Revisiting Methodologies for In Vitro Preparations of Advanced Glycation End Products

  2022cites this paper
• The Role of Vascular Cells in Pancreatic Beta-Cell Function

  2021cites this paper
• Contribution of RAGE axis activation to the association between metabolic syndrome and cancer

  2021cites this paper
• Comprehensive in vitro antidiabetic screening of Aspalathus linearis using a target-directed screening platform and cellomics.

  2021cites this paper
• In vitro chronic glycation induces AGEs accumulation reducing insulin stimulated glucose uptake and increasing GLP1R in adipocytes.

  2021cites this paper
• Dietary Advanced Glycation End Products as Mediators of Obesity: Cellular and Molecular Mechanisms of Action

  2021cites this paper
• Salt-Sensitivity of Blood Pressure and Insulin Resistance

  2021cites this paper
• Sarcopenia in Chronic Kidney Disease: Focus on Advanced Glycation End Products as Mediators and Markers of Oxidative Stress

  2021cites this paper
• Comprehensive overview of human serum albumin glycation in diabetes mellitus

  2021cites this paper
• Nutrient regulation of inflammatory signalling in obesity and vascular disease.

  2021cites this paper
• Effect of dietary advanced glycation end-products restriction on type 2 diabetes mellitus control: a systematic review.

  2021cites this paper
• Comprehensive in vitro antidiabetic screening of Aspalathus linearis using a target-directed screening platform and cellomics

  2020cites this paper
• The Impact of Low Advanced Glycation End Products Diet on Metabolic Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

  2020cites this paper
• Role of advanced glycation end products and insulin resistance in diabetic nephropathy

  2020cites this paper
• Comparative in vitro studies of antiglycemic potentials and molecular docking of Ageratum conyzoides L. and Phyllanthus amarus L. methanolic extracts

  2020cites this paper
• Oral Administration of Spa-derived Green Alga Improves Insulin Resistance in Overweight Subjects: Mechanistic Insights from Fructose-fed Rats.

  2020cites this paper
• The effect of omega-3 fatty acids and vitamin E co-supplementation on glycemic profile: A systematic review and meta-analysis of randomized controlled trials

  2020cites this paper
• Diabetes as a risk factor for Alzheimer’s disease in the Middle East and its shared pathological mediators

  2019cites this paper
• Accumulation of advanced glycation end products in the skin is accelerated in relation to insulin resistance in people with Type 1 diabetes mellitus

  2019cites this paper
• Effect of reducing dietary advanced glycation end products on obesity-associated complications: a systematic review.

  2019cites this paper
• The beneficial effects of N-acetyl cysteine (NAC) against obesity associated complications: A systematic review of pre-clinical studies.

  2019cites this paper
• Advanced Glycation End Products of Bovine Serum Albumin Suppressed Th1/Th2 Cytokine but Enhanced Monocyte IL-6 Gene Expression via MAPK-ERK and MyD88 Transduced NF-κB p50 Signaling Pathways

  2019cites this paper
• RAGE/NF-κB pathway mediates hypoxia-induced insulin resistance in 3T3-L1 adipocytes.

  2019cites this paper
• Advanced Glycation End Products: Building on the Concept of the "Common Soil" in Metabolic Disease.

  2019cites this paper
• The Role of Nonenzymatic Post-translational Protein Modifications in Uremic Vascular Calcification.

  2019cites this paper
• Advanced glycation end-products regulate extracellular matrix-adipocyte metabolic crosstalk in diabetes

  2019cites this paper
• Stress oxydant et glycoxydation : impact des produits avancés de glycation sur les mitochondries des cellules endothéliales dans le cadre de la pathologie diabétique

  2018cites this paper
• A new glycotoxin inhibitor mitigates diabetes in genetic mice model

  2018cites this paper
• Effects of a Low Advanced Glycation End Products Diet on Insulin Levels: The Feasibility of a Crossover Comparison Test

  2018cites this paper
• A new indanedione derivative alleviates symptoms of diabetes by modulating RAGE-NF-kappaB pathway in db/db mice.

  2018cites this paper
• Advanced glycation end products-induced insulin resistance involves repression of skeletal muscle GLUT4 expression

  2018cites this paper
• The advanced glycation end product Nϵ‐carboxymethyllysine and its precursor glyoxal increase serotonin release from Caco‐2 cells

  2018cites this paper
• With Great Age Comes Great Metastatic Ability: Ovarian Cancer and the Appeal of the Aging Peritoneal Microenvironment

  2018influential citation
• The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review

  2018cites this paper
• Diabetes mellitus and male infertility

  2018cites this paper
• N-acetylcysteine Counteracts Adipose Tissue Macrophage Infiltration and Insulin Resistance Elicited by Advanced Glycated Albumin in Healthy Rats

  2017cites this paper
• Hyperglycemia and advanced glycation end products (AGEs) suppress the differentiation of 3T3-L1 preadipocytes

  2017cites this paper
• Methylglyoxal-induced glycation changes adipose tissue vascular architecture, flow and expansion, leading to insulin resistance

  2017cites this paper
• A model of chronic diabetic polyneuropathy: benefits from intranasal insulin are modified by sex and RAGE deletion.

  2017cites this paper
• Glycated human albumin alters mitochondrial respiration in preadipocyte 3T3‐L1 cells

  2017cites this paper
• Glucagon-like peptide-1 secreting cell function as well as production of inflammatory reactive oxygen species is differently regulated by glycated serum and high levels of glucose PUDDU

  2017cites this paper
• The association between various smoking behaviors, cotinine biomarkers and skin autofluorescence, a marker for advanced glycation end product accumulation

  2017cites this paper
• Hyperglycemia and advanced glycation end products (AGEs) suppress the differentiation of 3T3-L1 preadipocytes.

  2017cites this paper
• Insulin Resistance and Alzheimer’s Disease: Bioenergetic Linkages

  2017cites this paper
• Relationship between soluble receptor for advanced glycation end products (sRAGE), body composition and fat distribution in healthy women

  2017cites this paper
• Advanced Glycation End Products Induce Obesity and Hepatosteatosis in CD-1 Wild-Type Mice

  2016cites this paper
• Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children

  2016cites this paper
• A new glycotoxins inhibitor attenuates insulin resistance in liver and fat cells.

  2016cites this paper
• DNA-aptamers raised against AGEs as a blocker of various aging-related disorders

  2016cites this paper
• Graphene based aptasensor for glycated albumin in diabetes mellitus diagnosis and monitoring.

  2016cites this paper
• Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?

  2016cites this paper
• Pathologic role of dietary advanced glycation end products in cardiometabolic disorders, and therapeutic intervention.

  2016cites this paper
• Stress oxydant et pathologie diabétique : impact de l'hyperglycémie et de l'albumine glyquée sur les cellules cardiaques et adipeuses

  2016cites this paper
• Nϵ‐Carboxymethyllysine Increases the Expression of miR‐103/143 and Enhances Lipid Accumulation in 3T3‐L1 Cells

  2016cites this paper
• Glycated albumin induces lipid infiltration in mice aorta independently of DM and RAS local modulation by inducing lipid peroxidation and inflammation.

  2016cites this paper
• Expression of the Receptor for Advanced Glycation End Products in Epicardial Fat: Link with Tissue Thickness and Local Insulin Resistance in Coronary Artery Disease

  2015cites this paper
• Serum advanced glycation end products are associated with insulin resistance in male nondiabetic patients with obstructive sleep apnea

  2015cites this paper
• Clinical and biochemical factors associated with area and metabolic activity in the visceral and subcutaneous adipose tissues by FDG-PET/CT.

  2015cites this paper
• Mechanisms for antidiabetic effect of gingerol in cultured cells and obese diabetic model mice

  2015cites this paper
• Compliance with an intense dietary intervention and glycemic control in type 2 diabetes

  2015cites this paper
• 26. Advanced glycation end products in infant formulas

  2014cites this paper
• Glycated albumin: an overview of the In Vitro models of an In Vivo potential disease marker

  2014cites this paper
• N&egr;-(Carboxymethyl)lysine-Receptor for Advanced Glycation End Product Axis Is a Key Modulator of Obesity-Induced Dysregulation of Adipokine Expression and Insulin Resistance

  2014cites this paper
• Advanced Glycation End Products and Diabetic Complications

  2014cites this paper
• DNA Aptamer Raised Against Advanced Glycation End Products (AGEs) Improves Glycemic Control and Decreases Adipocyte Size in Fructose-Fed Rats by Suppressing AGE-RAGE Axis

  2014cites this paper
• Glucagon-Like Peptide-1 Secreting Cell Function as well as Production of Inflammatory Reactive Oxygen Species Is Differently Regulated by Glycated Serum and High Levels of Glucose

  2014cites this paper
• Flushing response modifies the association of alcohol consumption with markers of glucose metabolism in Japanese men and women.

  2014cites this paper
• Consumption of a Diet Low in Advanced Glycation End Products for 4 Weeks Improves Insulin Sensitivity in Overweight Women

  2013cites this paper
• Effect of dietary advanced glycation end products on postprandial appetite, inflammation, and endothelial activation in healthy overweight individuals

  2013cites this paper
• Soluble HMGB1 Is a Novel Adipokine Stimulating IL-6 Secretion through RAGE Receptor in SW872 Preadipocyte Cell Line: Contribution to Chronic Inflammation in Fat Tissue

  2013cites this paper
• sRAGE is associated with low waist circumference and Hb levels in NAFLD

  2013cites this paper
• S100B Expression Modulates Diabetic Myocardium following Myocardial Infarction and Development of Diabetes

  2013influential citation
• Value of RAGE as a circulating biomarker : from sRAGE to anti-sRAGE autoantibodies

  2013cites this paper
• Intérêt du RAGE comme biomarqueur circulant : du sRAGE aux autoanticorps anti-sRAGE

  2013cites this paper
• S100B: role in cardiac remodeling and function following myocardial infarction in diabetes.

  2013cites this paper
• The receptor for advanced glycation end-products: a complex signaling scenario for a promiscuous receptor.

  2013cites this paper
• Aspalathin improves hyperglycemia and glucose intolerance in obese diabetic ob/ob mice

  2013cites this paper